Cargando…

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting

Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) overlap. It is not clear whether GERD is caused by non-erosive esophagitis, or erosive esophagitis. The Rome criteria are not widely used for the diagnosis of IBS in the clinic. In total, 1,489 IBS patients without red flags w...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Salhy, Magdy, Gilja, Odd Helge, Hatlebakk, Jan Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580027/
https://www.ncbi.nlm.nih.gov/pubmed/31180516
http://dx.doi.org/10.3892/mmr.2019.10284
_version_ 1783427954707005440
author El-Salhy, Magdy
Gilja, Odd Helge
Hatlebakk, Jan Gunnar
author_facet El-Salhy, Magdy
Gilja, Odd Helge
Hatlebakk, Jan Gunnar
author_sort El-Salhy, Magdy
collection PubMed
description Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) overlap. It is not clear whether GERD is caused by non-erosive esophagitis, or erosive esophagitis. The Rome criteria are not widely used for the diagnosis of IBS in the clinic. In total, 1,489 IBS patients without red flags were included in the present retrospective study. They comprised of 1,331 females and 158 males with a mean age of 51 years. The diagnosis of IBS was verified by endoscopic and histopathological examinations. Whereas erosive esophagitis occurred in 97% of patients, only 66% had GERD symptoms. Endoscopy and histopathological examinations revealed that 1.4% of the IBS patients with diarrhea as the predominant symptom had other organic gastrointestinal diseases: 0.3% with celiac disease, 0.2% with Crohn's disease, 0.07% with ulcerative colitis, 0.6% with microscopic colitis, and 0.2% with colon cancer. Applying the Rome III criteria produced a sensitivity of 100% [95% confidence intervals (CI)=99.8–100.0%] a specificity of 98.7% (95% CI=98.0–99.2%), a positive likelihood ratio of 76.9%, and a negative likelihood ratio of 0%. IBS is associated with erosive esophagitis. Applying Rome III criteria without red flags and history, was effective in diagnosing IBS. Celiac disease and microscopic colitis should be considered as alternative diagnoses.
format Online
Article
Text
id pubmed-6580027
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-65800272019-07-05 Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting El-Salhy, Magdy Gilja, Odd Helge Hatlebakk, Jan Gunnar Mol Med Rep Articles Irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD) overlap. It is not clear whether GERD is caused by non-erosive esophagitis, or erosive esophagitis. The Rome criteria are not widely used for the diagnosis of IBS in the clinic. In total, 1,489 IBS patients without red flags were included in the present retrospective study. They comprised of 1,331 females and 158 males with a mean age of 51 years. The diagnosis of IBS was verified by endoscopic and histopathological examinations. Whereas erosive esophagitis occurred in 97% of patients, only 66% had GERD symptoms. Endoscopy and histopathological examinations revealed that 1.4% of the IBS patients with diarrhea as the predominant symptom had other organic gastrointestinal diseases: 0.3% with celiac disease, 0.2% with Crohn's disease, 0.07% with ulcerative colitis, 0.6% with microscopic colitis, and 0.2% with colon cancer. Applying the Rome III criteria produced a sensitivity of 100% [95% confidence intervals (CI)=99.8–100.0%] a specificity of 98.7% (95% CI=98.0–99.2%), a positive likelihood ratio of 76.9%, and a negative likelihood ratio of 0%. IBS is associated with erosive esophagitis. Applying Rome III criteria without red flags and history, was effective in diagnosing IBS. Celiac disease and microscopic colitis should be considered as alternative diagnoses. D.A. Spandidos 2019-07 2019-05-23 /pmc/articles/PMC6580027/ /pubmed/31180516 http://dx.doi.org/10.3892/mmr.2019.10284 Text en Copyright: © El-Salhy et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
El-Salhy, Magdy
Gilja, Odd Helge
Hatlebakk, Jan Gunnar
Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title_full Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title_fullStr Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title_full_unstemmed Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title_short Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
title_sort overlapping of irritable bowel syndrome with erosive esophagitis and the performance of rome criteria in diagnosing ibs in a clinical setting
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580027/
https://www.ncbi.nlm.nih.gov/pubmed/31180516
http://dx.doi.org/10.3892/mmr.2019.10284
work_keys_str_mv AT elsalhymagdy overlappingofirritablebowelsyndromewitherosiveesophagitisandtheperformanceofromecriteriaindiagnosingibsinaclinicalsetting
AT giljaoddhelge overlappingofirritablebowelsyndromewitherosiveesophagitisandtheperformanceofromecriteriaindiagnosingibsinaclinicalsetting
AT hatlebakkjangunnar overlappingofirritablebowelsyndromewitherosiveesophagitisandtheperformanceofromecriteriaindiagnosingibsinaclinicalsetting